Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in BLLN — BillionToOne, Inc.

CIK 861177 NEW YORK, NY
Back to BLLN Full portfolio

Position in BLLN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$26,867,479
+$7,875,543 QoQ
Shares Held
223,933
-6.9% QoQ
Ownership
0.475%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 26% Shared 0% None 74%

Common Shares in BLLN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $5,355,433,839 across 31 Diagnostics & Research names. BLLN ranks #17 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 2,472,524 $1,239,624,627
2 DHR
Danaher Corp /De/
 5,012,228 $954,729,184
3 IDXX
Idexx Laboratories Inc /De
 911,489 $479,844,264
4 A
Agilent Technologies, Inc.
 2,544,780 $338,023,123
5 IQV
Iqvia Holdings Inc.
 1,634,264 $315,772,486
6 MTD
Mettler Toledo International Inc/
 238,684 $304,921,192
7 WAT
Waters Corp /De/
 774,955 $290,639,120
8 ILMN
Illumina, Inc.
 1,502,137 $264,120,743

All Filings in BLLN

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,867,479 223,933
2026-03-31 $18,991,936 240,587
2025-12-31 $18,631,284 227,655